A Study to Evaluate Efficacy and Safety of SAR441566 in Adults With Plaque Psoriasis
Completed · Phase 2 · NCT06073119
Conditions: Psoriasis
At a glance
- Research payments reported, 2025
- $332,852
- U.S. investigators named
- 12
- Sites paid
- 11
- Planned or actual enrollment
- 221
About the trial
- Sponsor
- Sanofi
- Tested
- SAR441566 (drug), Placebo (drug)
- Dates
- Started 2023-10-26; completion 2024-12-11
- Results posted
- Yes
This was a Phase 2, international, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, 12-week study. It was designed to assess the therapeutic dose, efficacy, and safety of treatment with SAR441566 in male and female adults with moderate to severe plaque psoriasis. Study details included a screening period (4 weeks and not less than 11 days before Day 1), a treatment period (12 weeks ± 3 days) and a post-treatment period (safety follow-up) (4 weeks ± 3 days). The total number of study visits was 7.
From ClinicalTrials.gov, last updated 2025-11-10. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Sanofi US Services Inc. reported $332,852 in research payments for this study in 2025 (42 payments).
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Todd M. Dreitzler, M.D. Family Medicine · Tempe, AZ
- Neal D. Bhatia, MD Dermatology · San Diego, CA
- Howard L. Sofen, M.D. Dermatology · Los Angeles, CA
- Javier Alonso-llamazares, M.D.PHD. Dermatology · Coral Gables, FL
- Igor Chaplik, DO Dermatology · Ft Lauderdale, FL
- Frank A. Don, D.O. Dermatology · Hallandale Beach, FL
- Alfonso Garcia-bello, M.D. Internal Medicine · Cape Coral, FL
- Hector Wiltz Jr, M.D Dermatology · Miami, FL
- Rica Santiago, M.D Internal Medicine · Mt Pleasant, SC
- Patricia C. Lee, M.D. Dermatology · Webster, TX
- Stephen K. Tyring, MD PHD Dermatology · Webster, TX
- Douglass W. Forsha, MD Legal Medicine (non-physician) · South Jordan, UT
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Phoenix Clinical Trials Scottsdale Clinical Trials $81,946
- Center for Clinical Studies Ltd LLP $77,694
- Driven Research Llc $38,691
- Direct Helpers Medical Center Inc Direct Helpers Research Center $33,536
- Dermatology Research Associates $30,722
- Fxm Clinical Research Ft Lauderdale Llc $23,295
- Fxm Clinical Research Miami Llc $17,872
- Jordan Valley Dermatology Research Center $10,196
- Renaissance Research and Medical Group, Inc $7,650
- Coastal Carolina Research Center $7,200
- Tcr Medical Corporation $4,050
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.